| Literature DB >> 22792439 |
Shinji Tokonami1, Masahiro Hosoda, Suminori Akiba, Atsuyuki Sorimachi, Ikuo Kashiwakura, Mikhail Balonov.
Abstract
A primary health concern among residents and evacuees in affected areas immediately after a nuclear accident is the internal exposure of the thyroid to radioiodine, particularly I-131, and subsequent thyroid cancer risk. In Japan, the natural disasters of the earthquake and tsunami in March 2011 destroyed an important function of the Fukushima Daiichi Nuclear Power Plant (F1-NPP) and a large amount of radioactive material was released to the environment. Here we report for the first time extensive measurements of the exposure to I-131 revealing I-131 activity in the thyroid of 46 out of the 62 residents and evacuees measured. The median thyroid equivalent dose was estimated to be 4.2 mSv and 3.5 mSv for children and adults, respectively, much smaller than the mean thyroid dose in the Chernobyl accident (490 mSv in evacuees). Maximum thyroid doses for children and adults were 23 mSv and 33 mSv, respectively.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22792439 PMCID: PMC3395030 DOI: 10.1038/srep00507
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Thyroid dose contour map.
The dose for one–year-old infants in the areas surrounding the reactor was estimated by SPEEDI (System for Prediction of Environmental Emergency Dose Information)15. Tsushima District of Namie Town is located within the 30-km-radius zone around the reactor. The figure was provided by the Asahi Shinbun and modified.
Figure 2Distribution of measured persons by thyroid equivalent dose from inhalation (A) and ingestion (B) of I-131.
Each dose was calculated according to I-131 activity in the thyroid and the age-dependent equivalent thyroid dose coefficient1617.
Number of persons by group, range of thyroid activity measured on April 12th to 16th, 2011, and equivalent thyroid dose
| Age group | Number of persons | I-131 thyroid activity range (kBq) | Thyroid dose range (mSv) : inhalation | Thyroid dose range (mSv) : ingestion |
|---|---|---|---|---|
| 0–9 | 5 | N.D.−0.017 | N.D.−21 | N.D.−24 |
| 10–19 | 3 | 0.090–0.54 | 3.8–23 | 4.2–25 |
| 20–29 | 9 | N.D.−0.59 | N.D.−16 | N.D.−17 |
| 30–39 | 6 | N.D.−0.17 | N.D.−4.4 | N.D.−4.9 |
| 40–49 | 4 | N.D.−1.5 | N.D.−33 | N.D.−37 |
| 50–59 | 10 | N.D.−1.1 | N.D.−31 | N.D.−34 |
| 60–69 | 12 | N.D.−0.20 | N.D.−5.3 | N.D.−5.8 |
| 70–79 | 3 | 0.090–1.5 | 2.3–31 | 2.5–34 |
| 80+ | 2 | N.D.−0.70 | N.D.−19 | N.D.−21 |
| Unknown | 8 | N.D.−1.4 | N.D.−28 | N.D.−30 |
Estimation of possible thyroid equivalent dose for children using the assumed maximum atmospheric I-131 concentration
| Age | Breathing volume per 4 h (m3) | Total I-131 intake (kBq) | Thyroid dose coefficient | Thyroid dose (mSv) |
|---|---|---|---|---|
| 3 months | 0.48 | 10.9 ± 0.9 | 3.3 | 36 ± 3 |
| 1 year | 0.86 | 19.7 ± 1.6 | 3.2 | 63 ± 5 |
| 5 years | 1.45 | 33.4 ± 2.6 | 1.9 | 63 ± 5 |
| 10 years | 2.55 | 58.5 ± 4.6 | 1.0 | 56 ± 4 |
| 15 years | 3.35 | 76.9 ± 6.1 | 0.6 | 48 ± 4 |